EGFR and cancer: Over-expression of Lewisy has been shown in the majority of cancer cells derived from epithelial tissues, however, including breast, ovary, pancreas, prostate, colon and non-small cell lung cancers [5], either at the plasma membrane as a glycolipid or linked to surface receptors (e.g. of the E-rb-B family) [6].